[Epidemiological features and mechanism of coronavirus disease 2019 in children]

Area of Science:

• Pediatric infectious diseases
• Immunology
• Virology

Background:

• Children generally experience less severe COVID-19 outcomes compared to adults.
• The underlying reasons for these age-related differences in disease severity are not fully understood.
• Investigating pediatric pathogenesis may reveal therapeutic targets for vulnerable populations.

Purpose of the Study:

• To explore the immunological and physiological factors contributing to milder COVID-19 in children.
• To identify potential protective mechanisms against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pediatric populations.
• To inform therapeutic strategies for high-risk adult populations by understanding pediatric resilience.

Main Methods:

• Review of existing literature on pediatric COVID-19.
• Analysis of the role of Human Angiotensin-Converting Enzyme Ⅱ (ACE2) receptor expression in age-related severity.
• Examination of immune system characteristics, regenerative capacities, and risk factor prevalence in children.

Main Results:

• Children's lower COVID-19 severity may be linked to decreasing ACE2 receptor expression with age, robust innate immunity, and efficient early viral clearance.
• Strong regenerative abilities of alveolar epithelial cells contribute to early recovery in children.
• Lower prevalence of risk factors like obesity and underlying cardiopulmonary diseases in children further reduces severity.

Conclusions:

• Pediatric resilience to severe COVID-19 is multifactorial, involving immune system dynamics, receptor expression, and cellular repair mechanisms.
• Children with immunodeficiency represent a high-risk group requiring close monitoring.
• Further research into the specific immune and protective mechanisms in children is essential for advancing COVID-19 treatment strategies.